Ankere Therapeutics ‘Ankere’ is venture-backed company focused on developing new pharmaceutical agents that target inflammatory conditions, particularly those of the lung.
The company was founded by Associate Professor Bernard Flynn Monash University Institute of Pharmaceutical Sciences (MIPS) and Professor Stuart Pitson (University of South Australia) and, built on decades of research. Ankere is striving to develop transformative therapies based on excellent science that will enable people to live long and healthy lives.
